Search results
US FDA approves Moderna's RSV vaccine with lower-than-expected efficacy in its label
AOL· 7 days agoFood and Drug Administration has approved Moderna's respiratory syncytial virus (RSV) vaccine, the company announced on Friday, giving it a shot at much-needed ...
Updated Covid-19 Vaccine Targeting JN.1 Recommended By FDA Panel
Forbes· 2 days agoRepresentatives from Moderna, Pfizer-BioNtech, and Novavax presented data about the protection...
Moderna Wins Second-Ever Approval. But It Could Dominate Pfizer, GSK.
Investor's Business Daily· 7 days agoLike rivals Pfizer (PFE) and GSK (GSK) — which gained their approvals and launched last year — ...
Moderna, Merck say vaccine improved survival in patients with deadly skin cancer
CNBC· 4 days agoModerna and Merck released more positive three-year data Monday on their experimental vaccine, given...
FDA approves Moderna’s RSV vaccine mRESVIA
Pharmaceutical Technology via Yahoo Finance· 4 days agoIn 2023, Moderna agreed to establish an mRNA manufacturing facility in Kenya. The new advanced facility will have the capacity to produce up to 500...
New COVID-19 vaccine for fall should target JN.1 lineage, not variant, FDA panel
USA TODAY via Yahoo News· 1 day agoOfficials noted that COVID-19 is rapidly evolving. The goal of the group was to capture the virus’...
Is Moderna Stock a Buy Now That It's a 2-Product Company? | The Motley Fool
The Motley Fool· 4 days agoThe shortened trading week that ended on May 31 was a strange one for the vaccine developer Moderna...
Moderna Investors Just Got Some Bullish News | The Motley Fool
The Motley Fool· 4 days agoModerna (MRNA 3.70%) jumped into the limelight when it started developing a coronavirus vaccine...
Moderna (MRNA) Secures FDA Nod for mRNA-Based RSV Vaccine
Zacks· 4 days agoThe RSV vaccine is Moderna???s (MRNA) second FDA-approved product. Once the vaccine secures the CDC's recommendation, it will be launched in the 2024-2025 respiratory virus season.
Moderna's Investigational Therapeutic for Methylmalonic Acidemia (mRNA-3705) Selected by U.S. Food &...
Morningstar· 19 hours agoCAMBRIDGE, MA / ACCESSWIRE / June 6, 2024 / Moderna, Inc. (NASDAQ:MRNA) today announced that the U.S. Food and Drug Administration (FDA) has selected mRNA-3705 for the Support ...